Are Endothelial Progenitor Cells Protective Factors on the Development of Cardiovascular Disease in Type 1 Diabetic Patients?

被引：0
|
作者：
Gong, Jennifer H.
Keenan, Hillary A.
Sun, Jennifer K.
Turek, Sara J.
Hastings, Stephanie M.
Chen, Liming
King, George L.
机构：
来源：
DIABETES | 2011年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
272-OR
引用
收藏
页码：A74 / A75
页数：2
相关论文
共 50 条
  • [31] Endothelial Progenitor Cells Carrying Monocyte Markers Are Selectively Abnormal in Type 1 Diabetic Patients With Early Retinopathy
    Zerbini, Gianpaolo
    Maestroni, Anna
    Palini, Alessio
    Tremolada, Gemma
    Lattanzio, Rosangela
    Maestroni, Silvia
    Pastore, Matteo Rocco
    Secchi, Antonio
    Bonfanti, Riccardo
    Gerhardinger, Chiara
    Lorenzi, Mara
    DIABETES, 2012, 61 (04) : 908 - 914
  • [32] Endothelial progenitor cells (CD34+/KDR+) are reduced in Type 1 diabetic patients with microalbuminuria
    Gnudi, L.
    Karalliedde, J.
    Hernandez-Fuentes, M.
    Dattani, N.
    Atkar, R.
    Maltese, G.
    De Angelis, L.
    Viberti, G. C.
    DIABETIC MEDICINE, 2007, 24 : 47 - 47
  • [33] Diminished endothelial progenitor cells are related to glycaemic control in type 1 diabetic children
    Schernthaner, G. H.
    Rami, B.
    Satler, M.
    Hoellerl, F.
    Hobaus, C.
    Schober, E.
    Schernthaner, G.
    DIABETOLOGIA, 2008, 51 : S14 - S15
  • [34] Dysbalance of endothelial and smooth muscle progenitor cells in diabetic patients with coronary artery disease
    Ruethlein, A.
    Fleissner, F.
    Jakob, M.
    Ertl, G.
    Bauersachs, J.
    Thum, T.
    EUROPEAN HEART JOURNAL, 2009, 30 : 739 - 739
  • [35] Cardiovascular risk factors and disease management in type 2 diabetic patients with diabetic nephropathy
    Sasso, FC
    De Nicola, L
    Carbonara, O
    Nasti, R
    Minutolo, R
    Salvatore, T
    Conte, G
    Torella, R
    DIABETES CARE, 2006, 29 (03) : 498 - 503
  • [36] Circulating endothelial progenitor cells and cardiovascular morbidity and mortality in patients with coronary artery disease
    Werner, N
    Kosiol, S
    Schlegl, T
    Ahlers, P
    Walenta, K
    Link, A
    Nickenig, G
    CIRCULATION, 2005, 112 (17) : U815 - U815
  • [37] The Effect of Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors on Circulating Endothelial Progenitor Cells in Patients with Cardiovascular Disease
    Osnat Itzhaki Ben Zadok
    Aviv Mager
    Dorit Leshem-Lev
    Eli Lev
    Ran Kornowski
    Alon Eisen
    Cardiovascular Drugs and Therapy, 2022, 36 : 85 - 92
  • [38] The Effect of Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors on Circulating Endothelial Progenitor Cells in Patients with Cardiovascular Disease
    Ben Zadok, Osnat Itzhaki
    Mager, Aviv
    Leshem-Lev, Dorit
    Lev, Eli
    Kornowski, Ran
    Eisen, Alon
    CARDIOVASCULAR DRUGS AND THERAPY, 2022, 36 (01) : 85 - 92
  • [39] Endothelial progenitor cells: Cardiovascular protection in Parkinson's disease?
    Pezzoli, Gianni
    Cavanna, Ferruccio
    Cassani, Erica
    Barichella, Michela
    Pinelli, Giovanna
    Iorio, Laura
    Pusani, Chiara
    Canesi, Margherita
    Natuzzi, Francesca
    Cazzola, Roberta
    Cestaro, Benvenuto
    Cereda, Emanuele
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 197 : 200 - 202
  • [40] Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies
    Kawamoto, Atsuhiko
    Asahara, Takayuki
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2007, 70 (04) : 477 - 484
12345